norstella-logo-white
Contact us

News & events

Keep up with the latest news, insights and events from Norstella and its market-leading brands

News | Insights | Events

News

Press Releases | Mar. 18, 2025

Norstella named to Fast Company’s annual list of the world’s most innovative companies of 2025

New York – March 18, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to have been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of 2025. This year’s list shines a spotlight on businesses that are shaping industry and culture through their innovations to set new standards and achieve remarkable milestones in all sectors of the economy. Read more
Press Releases | Feb. 05, 2025

Neelesh Sali named Managing Director & Country Head of Norstella India

New York – February 5, 2025 – Norstella, a leading global provider of pharma intelligence solutions, is proud to announce the appointment of Neelesh Sali as Managing Director and Country Head for India. With over 30 years of leadership experience driving operational excellence and scaling global organizations, Neelesh brings a proven track record of transformative growth and innovation to Norstella’s mission of smoothing the path to life-saving treatments. Read more
Press Releases | Feb. 04, 2025

NorstellaLinQ data source added to Atropos Evidence™ Network, scoring in the top decile for data quality on Real World Fitness Score®

Palo Alto, CA – February 4, 2025 – Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence (RWE) for care, announces the availability of an initial dataset from NorstellaLinQ on the Atropos Evidence Network. NorstellaLinQ, built by Norstella, one of the largest global pharma intelligence solution providers, is the first and only fully integrated data asset combining real-world data (RWD) and proprietary intelligence from the most trusted brands in the industry, paving the way for breakthroughs in drug development and commercialization. Read more
In the news | Jan. 16, 2025

NorstellaLinQ in the news

Since introducing NorstellaLinQ, biopharma’s first fully integrated data asset combining RWD and our wealth of proprietary information, we have been busily meeting with customers to explain how it can support their workflows. It is not only our pharma partners that have taken notice, but the trade media has also wanted to learn more. Suzanne Caruso, General Manager for Clinical & Regulatory at Norstella, met with reporters from STAT and Precision Medicine Online to explain. Read more
In the news | Nov. 20, 2024

Norstella recognized as company of the year in the 2024 BIG Awards for Business

Norstella is pleased to announce that the Business Intelligence Group has selected the company as a winner in its hotly contested "Company of the Year" category. This recognition, part of the broader 2024 BIG Awards for Business, celebrates those companies, products, and leaders making a significant impact by reshaping their industries and setting new standards for success. For Norstella, it signifies the considerable progress we are making against our mission to to smooth the path to lifesaving therapies for patients and providers. Read more
Press Releases | Oct. 08, 2024

Norstella introduces NorstellaLinQ, the biopharma industry’s first fully integrated data asset

NEW YORK – October 8, 2024 - Today, Norstella unveiled NorstellaLinQ, the biopharma industry’s first and only fully integrated data asset combining both real-world data (RWD) — including open and closed claims, lab results and structured and unstructured electronic medical records (EMR) — with Norstella’s proprietary forecasting, clinical, regulatory, payer, coverage and commercial intelligence data. Read more
Press Releases | Sep. 05, 2024

Panalgo introduces IHD Cloud, a transformative solution for RWE data and analytics centralization

Boston, MA - Sept. 5, 2024 - Panalgo, a Norstella company committed to revolutionizing healthcare data analytics, is announcing the launch of IHD Cloud, a cutting-edge solution that will transform how organizations manage and use real-world data (RWD) to generate real-world evidence (RWE). Powered by Amazon Web Services (AWS), IHD Cloud offers a scalable and flexible platform to centralize data and technology, driving meaningful and timely insights for any evidence generating organization. Read more
Press Releases | Aug. 13, 2024

In a first for pharma, Citeline SmartSolutions take AI to new levels, optimizing clinical trial planning and site selection

NEW YORK – Aug. 13, 2024 – Citeline, a leader in intelligence solutions for the life sciences industry, has launched two new products — Protocol SmartDesign and Investigator SmartSelect — in its Citeline SmartSolutions suite accelerating the path from pipeline to patient. Citeline SmartSolutions, an industry first, enables users to design and conduct more predictable trials by connecting the robust data assets already trusted by over 3,000 Citeline customers. Read more
Press Releases | Jun. 17, 2024

Atropos Health partners with Norstella to expand the Atropos Evidence™ Network and structured clinical trial intelligence

BOSTON – June 17, 2024 – Norstella, one of the largest global pharma intelligence solution providers, today announced a strategic partnership with Atropos Health, the pioneer in translating real-world clinical data into high-quality personalized real-world evidence for care. This collaboration follows Atropos Health’s recent announcement of $33 million in Series B funding, furthering its expansion into life sciences. Read more
Press Releases | Jan. 10, 2024

Evaluate, a Norstella company, announces acquisition of J+D Forecasting

January 8, 2024, London, UK and Boston, MA – Evaluate, a Norstella company, announced today the acquisition of J+D Forecasting, a leading provider of forecasting solutions for the pharmaceutical industry. Read more
Press Releases | Dec. 04, 2023

MMIT wins Titan Health Award for healthcare innovation

December 4, 2023, Yardley, PA – MMIT, a Norstella company and the trusted go-to-market partner for overcoming barriers to patient access, is excited to announce that its Patient Access Analytics solution has won a Titan Health Award, which celebrates and recognizes extraordinary achievements in healthcare advertising and marketing. Read more
Press Releases | May. 16, 2023

Industry veteran Fred Hassan joins the board of Norstella

Norstella, a leader in helping patients gain access to life-saving therapies by navigating the complexities at each step of the drug development life cycle, is pleased to announce that Fred Hassan has joined its board of directors. Hassan brings a wealth of experience and expertise in healthcare, having served as CEO of several major pharmaceutical companies and as a board member of numerous healthcare organizations. He has held senior leadership roles at some of the world's most prominent organizations, including Schering-Plough, Pharmacia Corporation, and Bausch & Lomb. Read more
Press Releases | Apr. 04, 2023

TriNetX and Clinerion unite as TriNetX and Norstella announce strategic partnership

Cambridge, MA, April 4, 2023 — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of novel therapies, and Norstella, the leading pharmaceuticals solutions provider, today announced a multi-faceted strategic partnership. As part of this exciting partnership, TriNetX will acquire Norstella’s Clinerion Ltd. subsidiary, expanding the growth of the world’s leading research network for real world data (RWD). Read more
Press Releases | Mar. 30, 2023

Citeline launches TrialScope intelligence, meeting the growing complexities of clinical trial disclosure

Clinical trial disclosure compliance is challenging, whether a sponsor is registering five trials or 500 trials. Compounding the complexity is the fact that no global standards exist for disclosure. With ever-changing global regulations, new requirements on the rise and the threat of monetary penalties, study sponsors are feeling the pressure to maintain compliance, minimize risk and safeguard their brand reputation. Read more
In the news | Mar. 07, 2023

How robust data technology is transforming the design and execution of viable clinical trials

While incorporating real-world data (RWD) and real-world evidence (RWE) across the drug development lifecycle is getting a lot of attention, the application of such insights gleaned from rigorous analysis to the design and execution of clinical trials has yet to be widely adopted, despite its potential to address some of these persistent challenges. Read more
In the news | Jan. 08, 2023

What do you view as the most disruptive or transformational technology or development on the horizon?

Norstella CEO, Mike Gallup, weighs in on the most disruptive / transformational technology on the horizon in a recent pharma’s almanac piece. “As regulators and payers look for new information to guide their decision-making, real-world data and evidence are poised to play a transformative role in not only getting drugs to market quickly, but also ensuring that patients can access them.” Read more
Press Releases | Dec. 09, 2022

Exclusive AIS Health data outlines 2021 compensation for health insurer CEOs

Washington, DC, Dec. 9, 2022 — In AIS Health’s annual roundup of health insurer executive compensation data, four newly public startup insurers stand out. But the stock awards that are largely driving their eye-popping total compensation figures — such as Clover Health Investments Corp. CEO Vivek Garipalli’s $390 million or Bright Health Group, Inc. CEO Mike Mikan’s $181 million — are based in part on the firms’ initial public offering (IPO) stock valuations, which were many times higher than what their shares are now worth. Read more
In the news | Nov. 14, 2022

Industry leaders offer reflections on 2022 and predictions for 2023

The COVID-19 pandemic has continued to evolve, forcing companies to adapt to a constantly changing landscape filled with fluid consumer expectations. Meanwhile, several other key healthcare-related trends have bubbled to the surface over that period. Read more
In the news | Nov. 14, 2022

What can we expect in pharma in 2023?

Drug pricing, CMS getting negotiating power for drug purchasing, vaccines, clinical trials, artificial intelligence, and Pharmacists becoming care givers. These are the highlights of 2022, what do the experts say we will see in 2023? We rounded up some experts and asked them just that. And join us for the next few weeks as we look at what we might see in 2023. Read more
In the news | Nov. 14, 2022

The 2023 PharmaVoice crystal ball: peering into the future of life sciences

For the 2023 PharmaVoice Year in Preview, we zeroed in on six key trends: clinical trial diversity, disruptive tech, innovation, talent management, patient engagement and leading through uncertain times. Here, we’ve asked industry execs to look into their crystal balls and tell us about anything they see coming. Read more
Press Releases | Nov. 01, 2022

Citeline and Norstella complete merger to form a $5 billion global pharmaceutical technology company

Nov. 1, 2022 – Norstella, a global leader with end-to-end solutions that smooth access to life-saving therapies for patients, has announced the completion of its merger with Citeline (formerly Pharma Intelligence), a leader in the clinical trial intelligence space. At deal close, the $5 billion global company is now one of the world’s largest pharma intelligence solutions providers on the market, with more than 1,600 employees across the five brands that make up Norstella: Evaluate, MMIT, Panalgo, The Dedham Group, and now Citeline. Read more
Press Releases | Jun. 28, 2022

Citeline and Norstella unite to offer life sciences clients a full suite of commercial and clinical solutions

June 28, 2022 – Norstella, an organization that helps life sciences companies navigate the complexities of the drug life cycle, and Citeline (formerly Pharma Intelligence)—a leading provider of specialist intelligence, data and software for clinical trials, drug development and regulatory compliance—have announced an agreement to merge the companies. Read more
Press Releases | Jun. 23, 2022

MMIT announces winners of the Q1 2022 Patient Access Awards

June 23, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has launched the inaugural Patient Access Awards to honor pharmaceutical manufacturers committed to improving patient access to life-saving therapies. Read more
In the news | Jun. 22, 2022

Merger creates $5 billion pharma technology company

Norstella and Citeline (formerly Pharma Intelligence) have merged to form a $5 billion global company, one of the largest pharma intelligence solutions providers on the market. Read more
In the news | Jun. 22, 2022

Norstella, Citeline merge to create $5bn pharma tech firm

Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players in the pharmaceutical intelligence category. Read more
In the news | Jun. 22, 2022

Norstella completes acquisition of Citeline to form $5B pharma intelligence group

Although financial terms weren’t disclosed, Norstella estimates that it is now a $5 billion player in the market, the company said in a Nov. 1 press release. The acquisition was first announced in June. Read more
In the news | Jun. 22, 2022

Norstella completes merger with Citeline to form $5B pharma tech company

The combined company has more than 1,500 employees worldwide, including about 200 in the Philadelphia region. Read more
In the news | Jun. 22, 2022

Citeline, Norstella complete $5B merger

Citeline and Norstella announced the completion of their $5 billion merger Tuesday morning. The deal, first announced in late June, creates one of the world’s largest pharmaceutical intelligence solutions providers. The combined company has $5 billion and 1,600 employees. Citeline will join four other brands, Evaluate, MMIT, Panalgo and The Dedham Group, as part of Norstella. Read more
Press Releases | May. 09, 2022

MMIT announces the winners of the seventh-annual specialty pharmacy Patient Choice Awards

May 9, 2022, Yardley, PA – Managed Markets Insight & Technology (MMIT)—the trusted go-to-market partner for overcoming barriers to patient access—has announced the winners of the seventh-annual Specialty Pharmacy Patient Choice Awards.  Each year, MMIT hosts the Patient Choice Awards to honor specialty pharmacies that provide best-in-class customer satisfaction and overall patient care within four categories: Payer/PBM, Hospital and Health System, Independent and Retail. Read more
Press Releases | May. 03, 2022

Four prominent pharmaceutical solutions providers launch Norstella to drive innovation and get patients access to life-saving therapies faster

May 3, 2022 – Creating a hub for rapid innovation, four prominent pharmaceutical solutions providers—Evaluate, MMIT, Panalgo and The Dedham Group—are thrilled to announce the launch of Norstella. Read more
Press Releases | Feb. 17, 2022

MMIT announces game-changing solution for life sciences companies

Feb. 17, 2022, Yardley, PA – Following the acquisition of healthcare analytics company Panalgo in September 2021, Managed Markets Insight & Technology (MMIT) has announced the launch of Patient Access Analytics Read more
Press Releases | Sep. 28, 2021

MMIT/Evaluate acquire Panalgo

MMIT/Evaluate Acquire Panalgo to Bring Speed and Trust to Pharma Analytics and Decision-Making The move will result in a disruptive, market-leading analytics platform that provides on-demand insights across dozens of normalized real-world evidence and market access data sets that support decision-making from pipeline to prescription September 28, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT) and […] Read more
Press Releases | Aug. 20, 2021

MMIT and Evaluate

MMIT and Evaluate Join Forces to Offer an End-to-End View of the Pharmaceutical Market Landscape By combining their technology, data and expertise, MMIT and Evaluate will become a $1.6 billion global pharma commercial intelligence provider August 20, 2021, Yardley, PA — Managed Markets Insight & Technology (MMIT), LLC, the trusted go-to-market partner solely focused on solving the “what […] Read more
Press Releases | Apr. 27, 2021

MMIT & The Dedham Group unite to smooth access to therapy

The combined data, technologies and expertise of both organizations will positively impact patient access to life saving treatments April 27, 2021, Yardley, PA – Managed Markets Insight & Technology, LLC. (MMIT), the trusted go-to-market partner solely focused on solving the “what and why” of market access—so that patients don’t face delays when trying to access lifesaving […] Read more
See more news

Insights

Article | Apr. 24, 2025

The patient availability conundrum

Despite tremendous scientific and medical advances, the economics of investing in drug research and development are challenging. The long-term trend suggests increasing R&D costs, lengthy development timelines, and high rates of failure. There are many factors that influence a positive outcome, from individual drug development decisions up to wider regulatory frameworks, all of which are […] Read more
Article | Apr. 16, 2025

The resurgence of mental health drug development and why it matters

After decades of stagnation, the field of mental health drug development is finally seeing some movement. A wave of innovation, bolstered by new science, shifting public attitudes, and landmark regulatory moments, is transforming how we understand and treat mental health conditions. “It’s like we’ve been playing the same song on repeat,” says Emma Wille, a […] Read more
Article | Mar. 27, 2025

How unstructured EMR data helps pharma find patients

As therapies have become more complex, pharma companies are now challenged to achieve precision targeting within a much tighter timeframe. While claims data is readily available, one of its key limitations is the lack of timeliness. Many manufacturers now rely on specialized lab data—from imaging results to genetic testing and genomics—to identify eligible patients and […] Read more
Article | Mar. 10, 2025

Connecting the dots with NorstellaLinQ

Norstella’s VP of thought leadership, Daniel Chancellor, was invited to share his perspectives on the proliferation of data with the leading publication The Medicine Maker. The timing was perfect, coming shortly after we launched NorstellaLinQ, the biopharma industry’s first fully integrated data asset. The article explores various themes such as abundance, the importance of data […] Read more
See more insights

Events

Conference | May 2025

ISPOR

Join global healthcare leaders as they convene at ISPOR 2025, the leading global conference for Health Economics and Outcomes Research (HEOR). This must-attend event welcomes all healthcare stakeholders and is directly relevant to researchers and academicians, assessors and regulators, payers and policy makers, the life sciences industry, healthcare providers, and patient engagement organizations.
Learn more
Conference | May 2025

ASGCT Annual Meeting

The American Society of Gene and Cell Therapy’s (ASGCT) Annual Meeting is the premier event for gene and cell therapy professionals. The meeting is the best place for people in the field to learn from the latest scientific research, stay current on new technologies, and make career-advancing connections with peers.
Learn more
Conference | May 2025

Pricing & Contracting USA

Gain critical insights on Medicaid, government pricing, regulatory requirements, policy initiatives, and best practices to enhance pricing and contracting models.
Learn more
Conference | May 2025

CPhI North America

CPhI North America a major pharmaceutical industry trade show where companies across the entire US pharmaceutical supply chain, including API manufacturers, biopharma companies, and packaging providers, will showcase their products and services, providing a platform for networking and business development within the North American pharmaceutical community.
Learn more
Conference | May 2025

ASCO (Clinical Oncology)

Attend the 2025 ASCO Annual Meeting and be part of the most significant gathering of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
Learn more
Conference | June 2025

DIA Global Annual Meeting

DIA 2025 is the ultimate global gathering for industry pioneers, regulatory experts, and healthcare visionaries. This flagship event is more than just a conference—it's a catalyst for change, bringing together the brightest minds to shape the future of healthcare, drug development, and regulatory science.
Learn more
Conference | June 2025

BIO International

The BIO International Convention is the largest and most comprehensive event for biotechnology, representing the full ecosystem of biotech with 20,000 industry leaders from across the globe.
Learn more
Conference | June 2025

AHIP

AHIP draws together industry experts, policymakers, academics, and thought leaders to discuss the challenges and opportunities guiding greater health. These diverse and timely programs offer you an opportunity to connect with health care professionals from around the country to discuss strategies and initiatives focused on health policy, health insurance provider operations, and public programs.
Learn more
Conference | June 2025

Future Pharma

Future Pharma brings together heads of brands, marketing, commercial, digital, and patient advocacy/engagement as the only conference designed to align strategies and provide insights on commercial success. Bringing together 250 VPs and Directors, Future Pharma provides you with as many new connections as possible.
Learn more
Conference | August 2025

ISPE

This conference brings together more than 1,500 leaders representing industry, service providers, government/regulatory agencies, academia, consultants and students from many countries - all dedicated to advancing the health of the public.
Learn more
Conference | September 2025

Fierce Pharma Week

Fierce Pharma Week brings together four communities: Pharma Marketing, PR & Communications, Commercialization, and Medical Affairs. Through thought leadership, networking and new connections, communities can share common and unique challenges faced by their counterparts to better support each other.
Learn more
Conference | September 2025

Prime/Magellan Specialty Summit

This annual event will connect, elevate and transform relationships, with exceptional speakers, insightful panels and in-person sessions.
Learn more
Conference | September 2025

DPHARM: Disruptive Innovations

DPHARM is the conference that challenges and reports on innovation to shake up the way we do clinical trials to reduce patient/physician burden, drive greater inclusivity, access and efficiencies. We challenge how we want clinical trials to look by 2030 and share examples from those who are doing something about it.
Learn more
Conference | September 2025

Pharma CI US

Evaluate will be speaking at the largest conference for pharmaceutical, biotechnology, medical device, and diagnostic competitive intelligence executives.
Learn more
Conference | October 2025

Cell and Gene Meeting on the Mesa

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures.
Learn more
Conference | October 2025

The Pharmacy Show

The Pharmacy Show is a large-scale trade show and conference primarily focused on the community and primary care pharmacy sector in the UK. It serves as a platform for pharmacy professionals to network, learn about the latest innovations in the industry, and access educational sessions delivered by leading experts, featuring a wide range of exhibitors from pharmaceutical companies to medical technology providers.
Learn more
Conference | October 2025

NLSDays​

NLSDays gathers big pharma executives, investors and CEOs of biotech, pharma and medtech companies and discusses the road ahead for the life science industry.
Learn more
Conference | October 2025

SCOPE Europe

SCOPE Europe: Summit for Clinical Ops Executives offers three days packed with insights, new case studies, and networking. With six conferences, including two new additions. Attendees will explore the latest trends in clinical trial innovation, planning, and operations.
Learn more
Conference | October 2025

TechBio UK

TechBio UK combines cutting-edge technology with biological sciences, particularly focusing on advancements in drug discovery, healthcare diagnostics, and personalized medicine, positioning the UK as a global leader in this innovative sector with significant potential for growth in 2025; key aspects include leveraging AI, big data, and advanced computational tools to revolutionize life sciences research and patient care.
Learn more
Conference | October 2025

AMCP Nexus

AMCP Nexus attracts more than 3,000 member and non-member managed care decision-makers. Attendees include individuals from health plans, PBMs, biopharmaceutical companies, consultants, and other leaders working within managed care pharmacy.  Enjoy education sessions, attend industry workshops, and experience the Expo where exhibitors will showcase the latest innovations and newest products.
Learn more
Conference | November 2025

CNS Summit

The CNS Summit is a conference focused on the life sciences industry, bringing together leaders in research and development to collaborate, share knowledge, and discuss cutting-edge advancements in drug development, particularly within the central nervous system (CNS) space.
Learn more
Conference | November 2025

BIO Europe Fall

Bio Europe connects Europe’s top innovation centers with the global life sciences industry to cultivate thriving strategic partnerships. Find Evaluate at Booth #C162.
Learn more
Conference | November 2025

Clinical Data Disclosure Europe

Master global clinical data disclosure and compliance by unlocking clarity on EMA Policy 0070, Plain Language Summaries and data sharing best practices.
Learn more
Conference | November 2025

Obesity Week

The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy.
Learn more
Conference | November 2025

ISPOR EU

This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.
Learn more
Conference | November 2025

Medicon Valley Alliance Oncology Network Meeting

Medicon Valley Alliance (MVA) is the non-profit membership organization for the Danish-Swedish life science that engages members by co-hosting, launching and driving meetings, networks, seminars, conferences and projects that strengthen the collaboration, networking and knowledge-sharing in the regions’ life science community.
Learn more
Conference | December 2025

American Society of Hematology

The ASH annual meeting is the world's largest and most comprehensive hematology event of the year.
Learn more

Work with us

Join our mission

We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.

Work with us

Get in Touch

Let's connect

Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?

We want to hear from you